Rhonda Pearlman Joins Redwood Scientific Technologies As General Counsel

LOS ANGELES, July 13, 2015 /PRNewswire/ — Redwood Scientific Technologies, Inc. (Redwood) today announced the appointment of Rhonda Pearlman as General Counsel effective immediately. She will serve on the company’s Executive Leadership Team and will report directly to President and Chief Executive Officer Jason Cardiff.

“Rhonda Pearlman is an experienced and respected attorney with vast experience in the pharmaceutical industry,” said Cardiff. “She will be invaluable in the upcoming IPO and in the years ahead as we continue our success with new thin film products that meet the needs of consumers.”

As General Counsel, she will manage general corporate matters, debt and equity financing, litigation, and intellectual property.

Ms. Pearlman joins Redwood from the law offices of Stuart L. Melnick, LLC, Kramer Levin Naftalis & Frankel LLP, and Par Pharmaceutical, Inc. where she served as Contract Attorney. She has been an Associate at Baker & McKenzie, Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates, and at Schulte Roth & Zabel LLP. She earned her Bachelors of Science and Masters in Pharmacology as well as her Juris Doctor from the University of Sydney.

About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.

Back to blog